RUNX1 and colorectal carcinoma: To functionally characterize RUNX1's effects on CRLM, a CRC cell line (Caco-2 after three consecutive rounds of in vivo selection; hereafter referred to as F3) with enhanced migration and invasion capacities, along with pronounced liver metastatic potential, as previously confirmed 22, was employed in this research.